Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA DIVIS LABORATORIES AUROBINDO PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 23.0 66.0 34.8% View Chart
P/BV x 2.4 7.1 33.3% View Chart
Dividend Yield % 0.3 0.9 31.5%  

Financials

 AUROBINDO PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
DIVIS LABORATORIES
Mar-23
AUROBINDO PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7154,641 15.4%   
Low Rs3972,730 14.6%   
Sales per share (Unadj.) Rs424.2292.6 145.0%  
Earnings per share (Unadj.) Rs32.968.7 47.9%  
Cash flow per share (Unadj.) Rs54.181.6 66.3%  
Dividends per share (Unadj.) Rs3.0030.00 10.0%  
Avg Dividend yield %0.50.8 66.3%  
Book value per share (Unadj.) Rs458.1480.9 95.2%  
Shares outstanding (eoy) m585.94265.47 220.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.312.6 10.4%   
Avg P/E ratio x16.953.7 31.5%  
P/CF ratio (eoy) x10.345.2 22.7%  
Price / Book Value ratio x1.27.7 15.8%  
Dividend payout %9.143.7 20.9%   
Avg Mkt Cap Rs m325,753978,378 33.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2239,750 361.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,55477,675 320.0%  
Other income Rs m2,9063,447 84.3%   
Total revenues Rs m251,46081,122 310.0%   
Gross profit Rs m37,07023,691 156.5%  
Depreciation Rs m12,4463,432 362.7%   
Interest Rs m1,40520 7,167.3%   
Profit before tax Rs m26,12523,686 110.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8495,453 125.6%   
Profit after tax Rs m19,27718,234 105.7%  
Gross profit margin %14.930.5 48.9%  
Effective tax rate %26.223.0 113.9%   
Net profit margin %7.823.5 33.0%  
BALANCE SHEET DATA
Current assets Rs m214,59997,437 220.2%   
Current liabilities Rs m114,93815,331 749.7%   
Net working cap to sales %40.1105.7 37.9%  
Current ratio x1.96.4 29.4%  
Inventory Days Days218 246.1%  
Debtors Days Days66842 7.8%  
Net fixed assets Rs m176,66851,128 345.5%   
Share capital Rs m586531 110.4%   
"Free" reserves Rs m267,813127,140 210.6%   
Net worth Rs m268,399127,671 210.2%   
Long term debt Rs m6,1900-   
Total assets Rs m392,125148,565 263.9%  
Interest coverage x19.61,209.5 1.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 121.2%   
Return on assets %5.312.3 42.9%  
Return on equity %7.214.3 50.3%  
Return on capital %10.018.6 54.0%  
Exports to sales %33.785.7 39.3%   
Imports to sales %15.319.8 77.3%   
Exports (fob) Rs m83,70366,537 125.8%   
Imports (cif) Rs m38,06015,378 247.5%   
Fx inflow Rs m85,48366,537 128.5%   
Fx outflow Rs m41,44715,715 263.7%   
Net fx Rs m44,03650,822 86.6%   
CASH FLOW
From Operations Rs m23,86824,597 97.0%  
From Investments Rs m-39,778-27,076 146.9%  
From Financial Activity Rs m18,144-7,972 -227.6%  
Net Cashflow Rs m2,298-10,451 -22.0%  

Share Holding

Indian Promoters % 48.8 51.9 93.9%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 36.7 112.5%  
FIIs % 20.7 14.9 139.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 48.1 100.2%  
Shareholders   241,944 354,482 68.3%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Aurobindo Pharma vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Divis Laboratories Share Price Performance

Period Aurobindo Pharma Divis Laboratories S&P BSE HEALTHCARE
1-Day 1.82% 2.14% 1.18%
1-Month 5.96% -2.15% -0.75%
1-Year 113.07% 22.51% 61.82%
3-Year CAGR 7.78% -1.38% 18.16%
5-Year CAGR 7.18% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.